[LRMR] YoY Annual Result on 31-Dec-2018 [#FY]

Stock
[LRMR] Larimar Therapeutics, Inc.
Announcement Date
14-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#FY]
Profit Trend
YoY- -17.95%
Quarter Report
LRMR's Result
LRMR's Financial Summary
View:
Show?
Annual Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -50,636 -42,482 -23,132 -62,968 -52,928 -58,178 -74,286 -6.18%
Tax -326 -155 -94 -1,600 -900 -300 -946 -16.25%
NP -50,310 -42,327 -23,132 -61,368 -52,028 -57,878 -74,286 -6.28%
Tax Rate - - - - - - - -
Total Cost 50,310 42,327 23,132 61,368 52,028 57,878 74,286 -6.28%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -2.93 -3.56 -2.51 -22.85 -22.76 -25.44 -33.32 -33.29%
EPS Diluted -2.93 -3.56 -2.51 -22.85 -22.76 -25.44 -33.32 -33.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.